Microfluidic Protein Array with Optical Contrast Layer

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microarray devices face challenges in achieving quantitative analysis of antigens and antibodies from crude protein preparations, particularly in point-of-care settings, due to the need for highly purified proteins and complex optical detection methods, which are labor-intensive and often require dedicated, expensive equipment.

Innovation Solution

A microfluidic system with an optical contrast layer allows non-purified antigen preparations to be non-covalently coupled, enabling quantitative detection using a visually detectable, precipitating dye, capable of detecting binding over a dynamic range of at least three orders of magnitude, and can be performed using a commercially available scanner or CCD detector.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional microarray methods use highly purified proteins deposited on transparent carriers, then quantitative analysis is possible, but the process becomes labor-intensive and requires complex optical detection equipment

Engineering Contradiction:
Improvequantitative analysis capabilityVSAvoiddetection equipment complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs colorimetric detection using chromogenic substrates that produce visible color changes upon enzymatic reaction. This allows quantitative analysis through simple visual inspection or basic spectrophotometry, eliminating the need for complex fluorescence or luminescence detection equipment while maintaining measurement precision

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The invention uses disposable nitrocellulose membranes with pre-immobilized antigens that can be directly read with simple optical equipment. These single-use carriers eliminate the need for expensive, complex detection systems by providing a self-contained, easily readable assay platform

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of manufacture

If unpurified or partially purified proteins are used on transparent carriers, then sample preparation is simplified, but attachment to the carrier fails

Engineering Contradiction:
Improveprotein preparation simplicityVSAvoidantigen attachment reliability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent utilizes the inherent optical properties of nitrocellulose membranes, which provide a dark background that enhances visibility of colored precipitates formed by enzyme-substrate reactions. This allows direct detection without requiring transparent carriers, enabling use of unpurified proteins while maintaining reliable attachment through the membrane's protein-binding properties

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The invention combines nitrocellulose membrane material with enzyme-linked detection systems to create a composite assay platform. The nitrocellulose provides both structural support and protein-binding capability, while the enzyme-conjugated antibodies provide detection functionality, allowing unpurified antigens to be reliably immobilized and detected

Inventive Principle:
Principle #40Composite materials

3Reliability

If nitrocellulose membranes are used to couple unpurified proteins, then attachment is achieved, but quantitative analysis becomes impossible

Engineering Contradiction:
Improveantigen coupling capabilityVSAvoidquantitative detection capability
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent employs colorimetric detection using enzymes such as alkaline phosphatase or horseradish peroxidase conjugated to detection antibodies. These enzymes catalyze reactions with chromogenic substrates to produce colored precipitates whose intensity can be quantified, enabling precise measurement while using nitrocellulose membranes for antigen coupling

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The invention replaces complex optical measurement systems with simple colorimetric readouts that can be quantified using basic spectrophotometry or even visual assessment. This substitution maintains quantitative analysis capability while simplifying the detection system and enabling use of nitrocellulose membranes

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Productivity

If microarray spot size is reduced to increase analyte density, then throughput increases, but optical detection becomes more complex

Engineering Contradiction:
Improveanalyte densityVSAvoidoptical detection complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent uses colorimetric detection with chromogenic substrates that produce intense, visible color changes even at low antigen densities. This allows detection of small microarray spots with simple optical equipment, maintaining high analyte density without requiring complex fluorescence or confocal microscopy systems

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The invention optimizes the enzymatic reaction parameters and substrate concentrations to produce sufficiently strong colorimetric signals from small microarray spots. By adjusting enzyme conjugation levels, substrate incubation times, and chromogen concentrations, the system achieves detectable signals from high-density arrays using simple optical detection

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid, quantitative analysis of antigens and antibodies in less than an hour, using unpurified or partially purified proteins, with the ability to detect multiple pathogens from a minute blood sample, and provides a portable solution for point-of-care diagnostics.

Implementation Method 1

a precipitating or agglomerating dye that is visually detectable

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Implementation Method 2

a carrier having a surface that comprises an optical contrast layer

Methodology Applied
Scientific EffectOptical contrast: Absorption (EM radiation)

Data Source

PatentUS10260168B2Microfluidic devices and methods
Publication Date: 2019.04.16 RGT UNIV OF CALIFORNIA
  • US10260168B2 patent drawing
  • US10260168B2 patent drawing
  • US10260168B2 patent drawing

AI summary

Contemplated microfluidic devices and methods are drawn to protein arrays in which distinct and detergent-containing antigen preparations are deposited onto an optical contrast layer in a non-specific and non-covalent manner. Detection of binding a is carried out using a dye that precipitates or agglomerates to so form a visually detectable signal at a dynamic range of at least three orders of magnitude.